Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Liangyin Lv"'
Autor:
Wen Zhu, Yang Wang, Liangyin Lv, Hui Wang, Wenqiang Shi, Zexin Liu, Mingzhe Zhou, Jianwei Zhu, Huili Lu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 13, Iss 5, Pp 2071-2085 (2023)
Developing universal CARs with improved flexible targeting and controllable activities is urgently needed. While several studies have suggested the potential of CD16a in tandem with monoclonal antibodies to construct universal CAR-T cells, the weak a
Externí odkaz:
https://doaj.org/article/483d45883d214370b509b2c31a785f89
Autor:
Wen Zhu, Yang Wang, Liangyin Lv, Hui Wang, Wenqiang Shi, Zexin Liu, Wei Yang, Jianwei Zhu, Huili Lu
Publikováno v:
Microbial Cell Factories, Vol 21, Iss 1, Pp 1-14 (2022)
Abstract Background In previous work, we developed an E. coli extracellular secretion platform XTHHly based on the hemolysin A secretion system. It can produce bioactive peptides with simple purification procedures. However, the wider application of
Externí odkaz:
https://doaj.org/article/a6c85de1afd24049a4eed93d1e2d6dc1
Publikováno v:
Bioresources and Bioprocessing, Vol 8, Iss 1, Pp 1-14 (2021)
Abstract Background Although Escherichia coli has been widely used for the expression of exogenous proteins, the secretory expression in this system is still a big obstacle. As one of the most important secretion pathways, hemolysin A (HlyA) system o
Externí odkaz:
https://doaj.org/article/e4897279f99f4e04a8695522cd8919ca
Autor:
Liangyin Lv, Hui Wang, Wenqiang Shi, Yang Wang, Wen Zhu, Zexin Liu, Xiaoqu Chen, Chen Zheng, Wencheng Kong, Wei Li, Jianwei Zhu, Huili Lu
Publikováno v:
Applied Microbiology and Biotechnology. 106:7039-7050
Interleukin-15 (IL-15) is a promising candidate for cancer immunotherapy due to its potent immune-activating effects. There are several IL-15 molecules currently in clinical trials but facing shortages of poor half-life, circulation instability, or c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b87d8b4205dc48f1ac2aa5c8678b17f9
https://doi.org/10.1007/s00253-022-12209-1
https://doi.org/10.1007/s00253-022-12209-1
Publikováno v:
Bioresources and Bioprocessing, Vol 8, Iss 1, Pp 1-14 (2021)
Background Although Escherichia coli has been widely used for the expression of exogenous proteins, the secretory expression in this system is still a big obstacle. As one of the most important secretion pathways, hemolysin A (HlyA) system of E. coli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::722574105b8f178851a66e9430230090
https://doaj.org/article/e4897279f99f4e04a8695522cd8919ca
https://doaj.org/article/e4897279f99f4e04a8695522cd8919ca
Autor:
Wen Zhu, Yang Wang, Liangyin Lv, Hui Wang, Wenqiang Shi, Zexin Liu, Mingzhe Zhou, Jianwei Zhu, Huili Lu
Developing universal CARs with improved flexible targeting and controllable activities is urgently needed. While several studies have suggested the potential of CD16a in tandem with monoclonal antibodies to construct universal CAR T cells, the weak a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2941ebca4b02f04fd5732bc1b8543e2b
https://doi.org/10.1101/2022.10.23.513394
https://doi.org/10.1101/2022.10.23.513394
Autor:
Wenqiang Shi, Liangyin Lv, Nan Liu, Hui Wang, Yang Wang, Wen Zhu, Zexin Liu, Jianwei Zhu, Huili Lu
Despite the demonstrated immense potential of immune checkpoint inhibitors in various types of cancers, only a minority of patients respond to these therapies. Immunocytokines designed to deliver an immune-activating cytokine directly to the immunosu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8fea1d2d29975a768ac24b06d6c46cd
https://doi.org/10.1101/2022.03.15.484441
https://doi.org/10.1101/2022.03.15.484441